News

Feature: Biorepository and Tissue Biomarker Technology (BTBMT) Core

The goal of the Biorepository and Tissue Biomarker Technology Shared Resource (BTBMT) is to provide the infrastructure to support the life cycle and QA/QC of high quality biospecimens for cancer research. The multifaceted life cycle includes patient consenting, biospecimen acquisition, processing

UCSF, UC Berkeley and 3D Printer Carbon, Inc. Team Up to Create a Drug Sponge to Absorb Excess Chemotherapy Medication

We know that many anticancer drugs are poisonous, leaving doctors with the careful task of administering enough chemotherapy to stop the growth of cancer cells while minimizing any damage to a patient's other organs. Steven Hetts, MD is the chief of Interventional Neuroradiology at UCSF Mission Bay

Highlights from the Precision Medicine World Conference 2019

For the fourth year, UCSF co-hosted the Precision Medicine World Conference, which attracted attendees from 35 countries to hear about the growing prominence of data science, artificial intelligence, and deep learning that is creating a sea change in nearly every aspect of health care and biomedical

UCSF's novel approach to a therapeutic cancer vaccine may provide a new option for patients relapsing with AML

An experimental cancer vaccine in early-stage development at the University of California San Francisco has sparked hope that patients with acute myeloid leukemia (AML), an aggressive cancer of the blood, could one day have a life-saving alternative, especially those prone to relapse or unable to

Q & A with Thea Tlsty, PhD, on Leading International Team to Study Inflammation and Cancer

“The Grand Challenge is designed to address really big, intractable questions in cancer. The idea is not to make small, incremental steps, but to make a huge leap forward.” Thea Tlsty, PhD from UCSF.edu, 1/23/19 $26 Million 'Grand Challenge' Project Will Probe Role of Inflammation in Cancer Thea D

Common Pain Reliever Can Improve Survival in Head and Neck Cancer

Jennifer R. Grandis, MD, senior author of the study. Regular use of a common type of medication, such as aspirin and ibuprofen, significantly improves survival for a third or more patients with head and neck cancer, a new study led by UC San Francisco has found. Non-steroidal anti-inflammatory drugs

$26 Million 'Grand Challenge' Project Will Probe Role of Inflammation in Cancer

“The Grand Challenge is designed to address really big, intractable questions in cancer. The idea is not to make small, incremental steps, but to make a huge leap forward.” Thea Tlsty, PhD Related news: Q & A with Thea Tlsty, PhD, on Leading International Team to Study Inflammation and Cancer UC San